Li, Zhiping
Jiao, Xuanmao
Di Sante, Gabriele
Ertel, Adam
Casimiro, Mathew C.
Wang, Min
Katiyar, Sanjay
Ju, Xiaoming
Klopfenstein, D. V.
Tozeren, Aydin
Dampier, William
Chepelev, Iouri
Jeltsch, Albert http://orcid.org/0000-0001-6113-9290
Pestell, Richard G.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA70896, R01CA75503, R01CA86072)
Breast Cancer Research Foundation
Pennsylvania Department of Health
Article History
Received: 6 March 2018
Revised: 3 December 2018
Accepted: 8 January 2019
First Online: 4 February 2019
Compliance with ethical standards
:
: RGP holds ownership interests in, and serves as CSO/Founder of, the biopharmaceutical companies LightSeed, Inc. and is CMO and Board member of CytoDyn. RGP holds ownership interests (value unknown) in several issued and submitted patent applications. The remaining authors declare that they have no conflict of interest.